Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAF in CHB Patients With Mildly Elevated ALT and Significant Liver Injury
NCT04674423Phase 4Recruiting
- Sponsor
- National Cheng Kung University Hospital
- Start
- May 2020
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir alafenamide in Chronic Hepatitis B (CHB), sponsored by National Cheng Kung University Hospital. Started May 2020; status: recruiting.
02
Drugs
tenofovir alafenamide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04674423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04674423.